Predicting Recurrence and Progession of Non Muscle Invasive Urothelial Cell Carcinoma of Bladder by Clinical and Pathological Prognostic Factors
Korean Journal of Urological Oncology
;
: 1-10, 2015.
Article
in Korean
| WPRIM
| ID: wpr-34610
ABSTRACT
About 80% of Bladder cancer is non muscle invasive bladder cancer (NMIBC). Despite of appropriate therapy, a lot of NMIBC recur as a superficial tumor or progress to muscle invasive disease. Several studies about prognostic factors of recurrence and progression have reported a single risk factor variously according to each study. These efforts were developed to predict the risk by scoring system and large-scale studies had been conducted. These studies had limitations that their patients did not receive BCG (bacillus Calmette-Guerin) immunotherapy, immediate intravesical chemotherapy, second-look TUR (transurethral resection) in high-risk group. Through studies to date, patients with NMIBC have showed heterogenous prognosis and a more sophisticated scoring system can give personalized treatment and exact prediction.
Full text:
Available
Index:
WPRIM (Western Pacific)
Main subject:
Prognosis
/
Recurrence
/
Research Design
/
Urinary Bladder
/
Urinary Bladder Neoplasms
/
Risk Factors
/
Drug Therapy
/
Immunotherapy
/
Mycobacterium bovis
Type of study:
Etiology study
/
Prognostic study
/
Risk factors
Limits:
Humans
Language:
Korean
Journal:
Korean Journal of Urological Oncology
Year:
2015
Type:
Article
Similar
MEDLINE
...
LILACS
LIS